SNHG1 and hepatocellular carcinoma: Its reduced expression results in a higher TNB and increases the sensitivity of HCC cells to systemic agents, potentially impacting the response of patients to immunotherapy, thus highlighting the key role that SNHG1 can play in shaping the landscape of personalized and targeted interventions for HCC.